Mylan CEO Defends EpiPen Pricing in Congressional Testimony
iStock/Thinkstock(WASHINGTON) — Mylan Pharmaceuticals CEO Heather Bresch defended her company’s decision to increase the price of the EpiPen during a hearing held by the House Committee on Oversight and Government Reform Wednesday afternoon. “Price Read More